Contents & Editorial Board

01. Secondary Metabolites from Some Species of Albizzia: A Review

02. Effects of Solvent Polarity on Solvation Free Energy, Dipole Moment, Polarizability, Hyperpolarizability and Molecular Properties of Metronidazole

03. Comparative Evaluation of Analgesic, Anti-inflammatory and Anti-pyretic Effects of Synthetic Derivatives of Organoantimony (Ѵ) Ferocenyl Benzoate with Piroxicam

04. Antinociceptive, Anti-inflammatory and Hypoglycemic Activities of Terminalia citrina Leaves

05. Wild Cinchona (Neolamarckia cadamba) – Bioactivities of a Medicinal Plant of Bangladesh

06. Evaluation of Antifungal, Hemolytic and Cytotoxic Potential of Ethyl Acetate Extract of a New Marine Streptomyces sp. AIAH-10

07. Antifilarial Activity of Eucalyptus globulus Labill. Leaves Against Brugia malayi

08. Correlation of Thrombolytic and Membrane Stabilizing Activities with Total Flavonoid Content Aerial Parts of Spondias pinnata

09. Future Prospects and Barriers of Pharmaceutical Industries in Bangladesh

10. Formulation and In vitro Evaluation of Eudragit RL 100 Loaded Fexofenadine HCl Microspheres

11. Study of Preservatives and Stimulants in Commercial Soft Drinks

12. Removal of Levafix Red from Aqueous Solution with Treated Jute Stick and its Relevance to Pharmaceutical Field

13. Current Trend of Antibiotic Resistance in Lower Respiratory Tract Infections (LRTIs): An Experience in a Teaching Hospital in Bangladesh

14. Formulation and Evaluation of Sustained Release Matrix Tablets of Repaglinide

15. The aim of present investigation was to formulate and evaluate the sustained release matrix tablets of Repaglinide (RPGN). These matrix tablets were prepared by wet granulation method using synthetic and natural polymers like HPMC K4M, HPMC 100M

16. Phytochemical Screening, Cytotoxic and Anthelmintic Activities of Amorphophallus campanulatus (Roxb.), Avicennia marina (Forssk.) and Launaea sarmentosa (Willd.)

17. Development and Validation of HPTLC Method for Simultaneous Estimation of Emtricitabine, Rilpivirine and Tenofovir Disoproxil Fumarate in Combined Dosage form

18. Recent Health Issues

19. New Drug Approvals